Özlem Türeci
Founder chez BIONTECH SE
Fortune : 84 M $ au 31/03/2024
Profil
zlem Treci a fondé BioNTech SE et Ganymed Pharmaceuticals AG. Elle occupe actuellement le poste de présidente de Ci3 Management UG, de présidente de l'Association pour l'immunothérapie du cancer et de médecin en chef de BioNTech SE. Dans le passé, elle a occupé le poste de directrice générale et de médecin en chef chez Ganymed Pharmaceuticals AG. Le Dr Treci a obtenu un diplôme de premier cycle à l'Université de la Sarre.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIONTECH SE
0,38% | 31/12/2023 | 913 247 ( 0,38% ) | 84 M $ | 31/03/2024 |
Postes actifs de Özlem Türeci
| Sociétés | Poste | Début |
|---|---|---|
| BIONTECH SE | Founder | 02/06/2008 |
| Association For Cancer Immunotherapy | President | - |
| Ci3 Management UG | Chairman | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - |
Anciens postes connus de Özlem Türeci
| Sociétés | Poste | Fin |
|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | - |
Formation de Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG |
